Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
aTyr Pharma plans trial for Covid-19 respiratory complications
The drug candidate is being developed to treat interstitial lung diseases. Credit: Robina Weermeijer on Unsplash.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Noble Life Sciences
Noble Life Sciences is a contract research organisation (CRO) offering...
About
Noble Life Sciences is a contract research organisation (CRO) offering preclinical development solutions for drugs, vaccines and medical devices.
FollowMake an Enquiry
-
ACTide by Nubilaria
Nubilaria Srl is an Information Technology (IT) company founded in...
About
Nubilaria Srl is an Information Technology (IT) company founded in 1999. Our company has its origins in the design, management and distribution of complex database systems and innovative IT services under strict international security policies.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry